🇺🇸 MRK — Merck & Co., Inc.

Healthcare Compra
← Volver

Precio actual

150,33 USD

Máx. histórico

156,92

10 días

Split 1048:1000 del 03/06/2021

Caída desde máximo

-4,20%

Rango 52 semanas

77,58 – 156,92

Variación hoy

-1,32%

Cierre anterior

152,34

Rango de hoy

150,09 – 152,22

Volumen hoy

4.298.143

Información
Nombre completo
Merck & Co., Inc.
Divisa
USD
Mercado
NYSE
Sector
Healthcare
Industria
Drug Manufacturers - General
Empleados
73.000
PER ⓘ
120,26 (puede no estar actualizado)
Dividend yield
2,23% (puede no estar actualizado)
Precio objetivo analistas
149,50 USD (puede no estar actualizado)
Primera cotización
02/01/1962
Precio actualizado
hace 3 días
Sobre la empresa

Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.

Dividendos repartidos Total últimos 12 meses: 3,3600 USD · Yield: 2,24%
Fecha de pago Importe por participación
14/09/2022 0,6900 USD
14/06/2022 0,6900 USD
14/03/2022 0,6900 USD
14/12/2021 0,6900 USD
14/09/2021 0,6500 USD
14/06/2021 0,6500 USD
12/03/2021 0,6202 USD
14/12/2020 0,6202 USD
14/09/2020 0,5821 USD
12/06/2020 0,5821 USD
13/03/2020 0,5821 USD
13/12/2019 0,5821 USD
13/09/2019 0,5248 USD
14/06/2019 0,5248 USD
14/03/2019 0,5248 USD
Splits Registrados en el histórico de precios
Fecha Ratio
03/06/2021 1048:1000
17/02/1999 2:1
26/05/1992 3:1
26/05/1988 3:1
27/05/1986 2:1
01/06/1972 2:1
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
14/04/2011 31,81 32,48 31,75 32,31 +1,17% 2,31% 15.740.960
13/04/2011 32,08 32,11 31,84 31,94 -0,27% 0,83% 8.199.447
12/04/2011 31,89 32,22 31,86 32,02 -0,09% 1,14% 15.280.050
11/04/2011 32,14 32,30 31,98 32,05 -0,24% 1,01% 11.719.365
08/04/2011 31,97 32,16 31,87 32,13 +1,02% 0,90% 19.267.585
07/04/2011 31,90 31,90 31,55 31,80 -0,06% 1,11% 13.178.705
06/04/2011 31,76 31,92 31,63 31,82 +0,57% 0,90% 13.667.911
05/04/2011 31,62 31,71 31,50 31,64 -0,33% 0,66% 9.685.930
04/04/2011 31,81 31,84 31,69 31,75 +0,60% 0,48% 12.070.864
01/04/2011 31,54 31,73 31,49 31,56 +0,18% 0,76% 11.993.312
31/03/2011 31,56 31,85 31,49 31,50 -0,87% 1,15% 13.218.424
30/03/2011 31,52 31,95 31,50 31,77 +1,59% 1,42% 18.077.057
29/03/2011 31,00 31,30 30,94 31,28 +1,02% 1,17% 10.397.837
28/03/2011 31,05 31,15 30,91 30,96 -0,37% 0,80% 9.491.526
25/03/2011 31,22 31,39 31,05 31,08 -0,46% 1,10% 11.066.042
24/03/2011 31,33 31,39 31,05 31,22 +0,28% 1,10% 12.035.442
23/03/2011 31,01 31,17 30,93 31,14 +0,31% 0,80% 12.905.491
22/03/2011 31,03 31,26 30,97 31,04 +0,43% 0,92% 17.273.241
21/03/2011 30,62 31,09 30,57 30,91 +1,50% 1,68% 15.995.834
18/03/2011 30,32 30,52 30,21 30,45 +1,50% 1,01% 20.414.830
17/03/2011 29,83 30,17 29,73 30,00 +1,16% 1,47% 14.366.613
16/03/2011 30,34 30,40 29,64 29,66 -2,45% 2,52% 24.262.143
15/03/2011 30,37 30,57 30,26 30,40 -1,61% 1,04% 16.905.602
14/03/2011 31,01 31,11 30,77 30,90 -1,07% 1,08% 14.451.501
11/03/2011 30,98 31,40 30,98 31,23 -0,52% 1,36% 12.846.698
10/03/2011 31,69 31,74 31,34 31,39 -1,17% 1,26% 16.065.106
09/03/2011 31,40 31,95 31,40 31,77 +0,94% 1,73% 14.253.848
08/03/2011 31,47 31,57 31,32 31,47 +0,46% 0,82% 12.103.771
07/03/2011 31,49 31,55 31,22 31,33 -0,70% 1,03% 40.392.016
04/03/2011 31,63 31,83 31,34 31,55 -0,12% 1,57% 40.663.238